title: APOL1 and kidney disease: new insights leading to novel therapies.
authors.affiliation: Wake Forest School of Medicine, Winston-Salem, North Carolina. Electronic address: bfreedma@wakehealth.edu.
authors.forename: Barry I
authors.initials: BI
authors.lastname: Freedman
mesh_terms: D001741:Black or African American / Q000235:genetics*; D000075944:Apolipoprotein L1; D001053:Apolipoproteins / Q000235:genetics* / Q000502:physiology; D018450:Disease Progression; D046148:Donor Selection; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D005838:Genotype; D005923:Glomerulosclerosis, Focal Segmental / Q000175:diagnosis / Q000208:ethnology / Q000235:genetics; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000503:physiopathology; D006977:Hypertension, Renal / Q000175:diagnosis; D007674:Kidney Diseases / Q000208:ethnology / Q000209:etiology / Q000235:genetics* / Q000517:prevention & control; D008075:Lipoproteins, HDL / Q000235:genetics* / Q000502:physiology; D017582:Renal Replacement Therapy / Q000706:statistics & numerical data; D035703:Therapies, Investigational; D014019:Tissue Donors
chemical_list: C108666:APOL1 protein, human; D000075944:Apolipoprotein L1; D001053:Apolipoproteins; D008075:Lipoproteins, HDL